NCT01039194 - Drug-Drug Interaction to Study the Effect of BMS-708163 on Pharmacokinetics (PK) of Galantamine Extended Release (ER) | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

January 31, 2010

Primary Completion Date

April 30, 2010

Study Completion Date

April 30, 2010

Conditions

Alzheimer Disease

Interventions

DRUG

galantamine

Capsule, Oral, 8 mg (ER), once daily, Days 1-7

DRUG

galantamine

Capsule, Oral, 16 mg (ER), once daily, Days 8-24

DRUG

BMS-708163

Capsule, Oral, 125 mg, once daily, Days 15-24

Trial Locations (1)

Parexel International - Baltimore Epcu, Baltimore